Filing Impact
Filing Sentiment
Form Type
4
Quidel
Aug 13, 2025
QuidelOrtho Launches Certified Analyzer Program
Jul 29, 2025
[SCHEDULE 13G/A] QuidelOrtho Corporation SEC Filing
1.61B
66.81M
0.92%
114.59%
9.24%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
SAN DIEGO